Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST
ZIOP: 4.76 (+0.07), BSPM: 1.09 (-0.03), BDR: 2.36 (+0.06), ZAZA: 3.20 (+0.70), ACY: 8.50 (-0.05), NBS: 3.27 (+0.02), SYRX: 1.14 (+0.11), IAG: 2.41 (+0.06), THTI: 1.32 (+0.14), BITA: 72.57 (+0.36), VRTB: 3.49 (-0.12), OPTT: 0.63 (-0.01), INVT: 0.63 (+0.04), GERN: 3.06 (+0.05), VASC: 27.30 (+0.71), LOCM: 1.15 (+0.03), CTHR: 1.63 (-0.03), MOV: 27.58 (-0.41), IFON: 1.07 (-0.06), SVM: 1.25 (+0.09)
Biostar Pharma revenues down in Q3
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 9:00AM CST
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals EPS of $0.02
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:08AM CST
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results
PR Newswire - Fri Nov 14, 8:00AM CST
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer
PR Newswire - Thu Sep 18, 7:00AM CDT
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or the "Company"
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals elects Professor Xiaohui Zheng as its chief scientist
M2 - Thu Aug 28, 7:11AM CDT
Pharmaceutical company Biostar Pharmaceuticals (NasdaqCM:BSPM) said on Wednesday that Professor Xiaohui Zheng has been named as its chief scientist to preside over its product development projects.
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects
PR Newswire - Wed Aug 27, 7:00AM CDT
XIANYANG, China, Aug. 27, 2014 /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03)
Nasdaq stocks posting largest volume increases
AP - Thu Aug 21, 5:08PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
PNTR: 7.96 (+0.04), BSPM: 1.09 (-0.03), LNDC: 13.96 (-0.15), HPJ: 5.03 (+0.14), HMPR: 1.72 (+0.02), IMCB: 20.00 (+0.31), BSQR: 4.49 (+0.02), DGLY: 15.62 (+0.82), MGYR: 8.40 (+0.02)
Sinopharm, Biostar, Lilly Rise on Medical Modernization in China
at The Street - Mon Aug 18, 1:11PM CDT
Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments
BSPM: 1.09 (-0.03), BAX: 74.45 (-0.04), PFE: 31.42 (-0.03), LLY: 70.16 (+0.42), GSK: 42.85 (+0.11), SVA: 4.95 (+0.07), SNY: 46.35 (+0.50), CPHI: 0.38 (+0.01)
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
PR Newswire - Thu Aug 14, 7:00AM CDT
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals announces formation of hospital marketing team to open new sales channels in ten provinces in China
M2 - Tue Aug 05, 6:16AM CDT
Health supplement company Biostar Pharmaceuticals (NasdaqCM:BSPM) reported on Monday the establishment a dedicated sales and marketing team for developing and expanding the sales of its Huangyangning tablets, hyperthyroidism and Wenweishu capsules in ten provinces in China.
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals Inc. Established a Sales and Marketing Task Team to Promote Sales to Hospital Facilities in Ten PRC Provinces
PR Newswire - Mon Aug 04, 7:00AM CDT
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03)
Biostar Held Its Strategic Development Seminar; Identified Development Planning for 2014 - 2016
PR Newswire - Fri Feb 14, 7:00AM CST
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03)
Biostar Pharmaceuticals, Inc. Announces the Designation of its PRC Operating Subsidiary as the Shaanxi Province Liver Disease Health Education Base
PR Newswire - Wed Jan 15, 7:00AM CST
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"
BSPM: 1.09 (-0.03), AXN: 0.31 (+0.01)